Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

InVivo Therapeutics Holdings Corp.

www.invivotherapeutics.com

Latest From RaQualia Pharma Inc.

Takeda Gets GI Candidate – And Possibly Company – In Altos Deal

In the latest in a string of deals, Takeda's agreement to acquire global rights to Altos's gastroparesis candidate - and possibly the company itself - gives the Japanese giant another asset in its core gastrointestinal area.

BioPharmaceutical Asia Pacific

Japan Venture Taps ‘Deep Learning’ To Improve Drug Discovery

The Japanese peptide venture Interprotein is tapping into artificial intelligence technology with the hope of improving the efficiency and accuracy of its drug discovery efforts.

BioPharmaceutical Asia Pacific

RaQualia links with academia to boost research, cut costs

RaQualia Pharma sees a new collaboration with Nagoya University as having two main benefits: aiding its effort to find innovative new drugs and helping to control operational expenses.

Neurology

RaQualia moves provide year-end succor

Following the drastic cuts to its sales and profit forecasts for calendar 2013 in early November, RaQualia Pharma has taken two steps that will contribute to its business, one providing an immediate boost before the books close for the year.

Neurology Japan
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Medical Devices
    • Biomaterials
    • Implantable Devices
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
  • Therapeutic Areas
  • Musculoskeletal & Connective Tissue Disorders
  • Neurology, Nervous System
  • Wound Healing & Tissue Repair
  • Alias(es)
  • InVivo Therapeutics Corp.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • InVivo Therapeutics Holdings Corp.
  • Senior Management
  • Mark D Perrin, CEO
    Steven McAllister, CFO
    Thomas R Ulrich, MD, CSO
    Masuoka Lorianne, MD, CMO
    Christopher McNulty, SVP, Bus. Dev. & Investor Relations
    Pamela Stahl, Chief Commercial Officer
  • Contact Info
  • InVivo Therapeutics Holdings Corp.
    Phone: (617) 863-5500
    One Kendall Sq., Bldg. 1400 East, Fl. 4
    Cambridge, MA 02139
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register